- Home
- HLN vs IQV Comparison
HLN vs IQV Comparison
Compare HLN & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLN
- IQV
- Stock Information
- Founded
- HLN 2022
- IQV 1982
- Country
- HLN United Kingdom
- IQV United States
- Employees
- HLN N/A
- IQV N/A
- Industry
- HLN Package Goods/Cosmetics
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- HLN Consumer Discretionary
- IQV Health Care
- Exchange
- HLN Nasdaq
- IQV Nasdaq
- Market Cap
- HLN 43.9B
- IQV 38.1B
- IPO Year
- HLN N/A
- IQV 2013
- Fundamental
- Price
- HLN $9.71
- IQV $190.88
- Analyst Decision
- HLN Strong Buy
- IQV Strong Buy
- Analyst Count
- HLN 2
- IQV 16
- Target Price
- HLN $10.48
- IQV $256.27
- AVG Volume (30 Days)
- HLN 7.2M
- IQV 1.5M
- Earning Date
- HLN 08-01-2024
- IQV 02-12-2025
- Dividend Yield
- HLN 1.60%
- IQV N/A
- EPS Growth
- HLN N/A
- IQV 27.98
- EPS
- HLN 0.18
- IQV 7.62
- Revenue
- HLN $15,065,004,686.00
- IQV $15,315,000,000.00
- Revenue This Year
- HLN $2.92
- IQV $3.66
- Revenue Next Year
- HLN $2.80
- IQV $4.86
- P/E Ratio
- HLN $27.25
- IQV $25.21
- Revenue Growth
- HLN N/A
- IQV 3.10
- 52 Week Low
- HLN $7.89
- IQV $187.62
- 52 Week High
- HLN $10.80
- IQV $261.73
- Technical
- Relative Strength Index (RSI)
- HLN 50.02
- IQV 32.51
- Support Level
- HLN $9.70
- IQV $198.54
- Resistance Level
- HLN $9.95
- IQV $201.00
- Average True Range (ATR)
- HLN 0.11
- IQV 4.94
- MACD
- HLN 0.02
- IQV -0.13
- Stochastic Oscillator
- HLN 40.96
- IQV 0.42
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.